Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 4
2008 6
2009 6
2010 5
2011 6
2012 3
2013 1
2014 1
2015 2
2016 2
2017 5
2018 2
2020 3
2021 3
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Primary sclerosing cholangitis.
Rabiee A, Silveira MG. Rabiee A, et al. Among authors: silveira mg. Transl Gastroenterol Hepatol. 2021 Apr 5;6:29. doi: 10.21037/tgh-20-266. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 33824933 Free PMC article. Review.
Tracheobronchopathia osteochondroplastica.
Silveira MGM, Castellano MVCO, Fuzi CE, Coletta ENAM, Spinosa GN. Silveira MGM, et al. J Bras Pneumol. 2017 Mar-Apr;43(2):151-153. doi: 10.1590/S1806-37562016000000143. J Bras Pneumol. 2017. PMID: 28538784 Free PMC article.
IgG4-associated cholangitis.
Silveira MG. Silveira MG. Clin Liver Dis. 2013 May;17(2):255-68. doi: 10.1016/j.cld.2012.11.007. Epub 2012 Dec 20. Clin Liver Dis. 2013. PMID: 23540501 Review.
Primary sclerosing cholangitis.
Silveira MG, Lindor KD. Silveira MG, et al. Can J Gastroenterol. 2008 Aug;22(8):689-98. doi: 10.1155/2008/824168. Can J Gastroenterol. 2008. PMID: 18701947 Free PMC article. Review.
Hepatic fibrosis and the renin-angiotensin system.
Abbas G, Silveira MG, Lindor KD. Abbas G, et al. Among authors: silveira mg. Am J Ther. 2011 Nov;18(6):e202-8. doi: 10.1097/MJT.0b013e3181df8df5. Am J Ther. 2011. PMID: 20535005 Review.
Nutritional assay Pereskia spp.: unconventional vegetable.
Silveira MG, Picinin CTR, Cirillo MÂ, Freire JM, Barcelos MFP. Silveira MG, et al. An Acad Bras Cienc. 2020;92 Suppl 1:e20180757. doi: 10.1590/0001-3765202020180757. Epub 2020 Jun 1. An Acad Bras Cienc. 2020. PMID: 32491136 Free article.
53 results